Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Arch Soc Esp Oftalmol ; 78(4): 197-201, 2003 Apr.
Artigo em Espanhol | MEDLINE | ID: mdl-12743843

RESUMO

PURPOSE: To evaluate the efficacy of deep sclerectomy in the surgical treatment of glaucoma one year after surgery. METHODS: 53 eyes of 43 patients (26 male, 27 female) with medically uncontrolled glaucoma of various types, were treated with deep sclerectomy surgery. RESULTS: The mean postoperative intraocular pressure (IOP) was 18.19 S.D. 5.22 mmHg., and the mean preoperative IOP was 26.66 S.D. 5.93 mmHg. We observed a statistically significant reduction in the IOP (p<0.05). Our success criteria were IOP lower than 21 mmHg with or without associated hypotensive medications, no advance in glaucomatous visual field defects and no advance in optic nerve cupping. This was achieved in 88.68% of the cases at 12 months follow-up. CONCLUSIONS: Deep sclerectomy is an efficient technique to control IOP, with few early post-operative complications.


Assuntos
Glaucoma/cirurgia , Esclerostomia/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Glaucoma/patologia , Humanos , Pressão Intraocular , Masculino , Pessoa de Meia-Idade , Complicações Pós-Operatórias , Resultado do Tratamento
2.
Arch Soc Esp Oftalmol ; 79(8): 375-8, 2004 Aug.
Artigo em Espanhol | MEDLINE | ID: mdl-15306963

RESUMO

PURPOSE: To evaluate the efficacy of topical mitomycin C (MMC) 0.02% in treating conjunctival intraepithelial neoplasia (CIN). METHODS: Three patients with CIN were treated with topical MMC 0.02%. Our follow-up period was twelve months (range 8-18 months). RESULTS: CIN was resolved in all three cases without modifying the normal corneal and conjunctival architecture. CONCLUSIONS: Topical MMC 0.02% four times daily during two weeks is a useful alternative tool for the surgical management of CIN.


Assuntos
Antibióticos Antineoplásicos/uso terapêutico , Carcinoma in Situ/tratamento farmacológico , Neoplasias da Túnica Conjuntiva/tratamento farmacológico , Mitomicina/uso terapêutico , Administração Tópica , Idoso , Antibióticos Antineoplásicos/administração & dosagem , Carcinoma in Situ/patologia , Neoplasias da Túnica Conjuntiva/patologia , Humanos , Masculino , Mitomicina/administração & dosagem , Soluções Oftálmicas , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA